Peter Colabuono
Chief Executive Officer presso Ariagen, Inc.
Profilo
Mr. Peter Colabuono is a Director-Business Development & Finance at Silvergate Pharmaceuticals, Inc.
Mr. Colabuono was previously employed as an Associate by Frazier Management LLC, a Member by Cowen Group, Inc., and a Member by Morgan Stanley & Co. LLC.
He received his undergraduate degree from Dartmouth College.
Posizioni attive di Peter Colabuono
| Società | Posizione | Inizio |
|---|---|---|
Decheng Capital LLC
 Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | Private Equity Investor | 01/10/2016 |
Ariagen, Inc.
 Ariagen, Inc. Financial ConglomeratesFinance Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono. | Chief Executive Officer | - |
Precedenti posizioni note di Peter Colabuono
| Società | Posizione | Fine |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director/Board Member | 31/05/2022 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Analyst | 01/07/2011 |
Silvergate Pharmaceuticals, Inc.
 Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silvergate Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It specializes in reformulating adult drugs and supplies it to the pediatric market. The company was founded by Frank Segrave in 2010 and is headquartered in Greenwood Village, CO. | Director of Finance/CFO | - |
Cowen Group, Inc. /Old/
 Cowen Group, Inc. /Old/ Investment Banks/BrokersFinance Cowen Group, Inc. provides investment banking for small to midsized companies in the alternative energy, consumer health care, media, technology, and telecommunications industries. It offers mergers and acquisitions advice, securities underwriting, equity offerings, private equity placements, and market-making. The company was founded in 1918 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Corporate Officer/Principal | - |
Formazione di Peter Colabuono
| Dartmouth College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Cowen Group, Inc. /Old/
Cowen Group, Inc. /Old/ Investment Banks/BrokersFinance Cowen Group, Inc. provides investment banking for small to midsized companies in the alternative energy, consumer health care, media, technology, and telecommunications industries. It offers mergers and acquisitions advice, securities underwriting, equity offerings, private equity placements, and market-making. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
Silvergate Pharmaceuticals, Inc.
Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silvergate Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It specializes in reformulating adult drugs and supplies it to the pediatric market. The company was founded by Frank Segrave in 2010 and is headquartered in Greenwood Village, CO. | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Finance |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | Finance |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
Ariagen, Inc.
Ariagen, Inc. Financial ConglomeratesFinance Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono. | Finance |
- Borsa valori
- Insiders
- Peter Colabuono
